StockData
FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31

Fortrea Holdings Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$22.42−0.07 (-0.31%)

Close on Oct 19, 2026

Market cap
$2.13B
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Nov 4, 2026, before market open (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Jul 29, 2026Before market open$678.20M$-0.14$0.23
Q1 FY2026
Ended Mar 31, 2026
May 5, 2026Before market open$636.50M$-0.25$0.16
Q4 FY2025
Ended Dec 31, 2025
Feb 26, 2026Before market open$660.50M$-0.35$0.09
Q3 FY2025
Ended Sep 30, 2025
Nov 5, 2025Before market open$701.30M$-0.17$0.12
Q2 FY2025
Ended Jun 30, 2025
Aug 6, 2025Before market open$710.30M$-4.14$0.19
Q1 FY2025
Ended Mar 31, 2025
May 12, 2025Before market open$651.30M$-6.25$0.02
Q4 FY2024
Ended Dec 31, 2024
Mar 3, 2025Before market open$697.00M$-0.82$0.18
Q3 FY2024
Ended Sep 30, 2024
Nov 8, 2024Before market open$674.90M$-0.31$0.23
Q2 FY2024
Ended Jun 30, 2024
Aug 12, 2024Before market open–––
Q1 FY2024
Ended Mar 31, 2024
May 13, 2024Before market open–––
Q4 FY2023
Ended Dec 31, 2023
Mar 11, 2024Before market open–––

Company guidance

Outlook given with results on Jul 29, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
adjusted EBITDAnon-GAAPfull-year 2026$205.00M to $220.00MRaised
revenuesfull-year 2026$2.62B to $2.69BRaised

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Fortrea filed with the SEC